{"id":16966,"date":"2023-11-09T13:25:35","date_gmt":"2023-11-09T18:25:35","guid":{"rendered":"https:\/\/www.ices.on.ca\/?post_type=private_project&p=16966"},"modified":"2025-02-28T11:09:53","modified_gmt":"2025-02-28T16:09:53","slug":"burden-of-illness-of-sickle-cell-disease-with-recurrent-vocs-in-ontario","status":"publish","type":"private_project","link":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-of-sickle-cell-disease-with-recurrent-vocs-in-ontario\/","title":{"rendered":"Burden of illness of sickle cell disease with recurrent vaso-occlusive crises (VOCs) in Ontario"},"content":{"rendered":"

Client:<\/strong> IQVIA Solutions Canada Inc.<\/p>\n

Project ID:<\/strong> P2023-176 \/ 2024 0970 350 000<\/p>\n

Research Question\/Objectives:<\/strong> The prevalence of complications and healthcare resource utilization (HCRU) of patients with SCD in the Canadian population is not well researched in the scientific literature. Patients with SCD with recurrent VOCs often seek medical care in emergency rooms and hospitals. Population-based studies using administrative healthcare databases are useful for identifying people living with rare diseases such as SCD and studying the associated burden of disease. This study will aim to identify patients with SCD with recurrent VOCs and describe their clinical and economic burden using administrative datasets<\/p>\n

Primary Objectives:<\/strong><\/p>\n

    \n
  1. Describe demographic characteristics of patients with SCD with recurrent VOCs and matched controls<\/li>\n
  2. Describe treatment patterns of patients with SCD with recurrent VOCs during follow-up<\/li>\n
  3. Assess the all-cause mortality rate in patients with SCD with recurrent VOCs and matched controls during follow-up<\/li>\n
  4. Estimate the prevalence and the rate of clinical complications in the patients with SCD with recurrent VOCs and in matched controls during follow-up<\/li>\n
  5. Determine HCRU of patients with SCD with recurrent VOCs and matched controls during follow-up<\/li>\n<\/ol>\n

    Exploratory Objective:<\/strong><\/p>\n

      \n
    1. Compare mortality and HCRU between patients with SCD with recurrent VOCs and matched controls in Ontario<\/li>\n<\/ol>\n

      Results:<\/strong> Completed<\/p>\n

      Results:<\/strong> March 2025<\/p>\n","protected":false},"excerpt":{"rendered":"

      Client: IQVIA Solutions Canada Inc. Project ID: P2023-176 \/ 2024 0970 350 000 Research Question\/Objectives: The prevalence of complications and healthcare resource utilization (HCRU) of patients with SCD in the Canadian population is not well researched in the scientific literature. Patients with SCD with recurrent VOCs often seek medical care in emergency rooms and hospitals. […]<\/p>\n","protected":false},"template":"","organization_type":[],"project_status":[105],"response_type":[],"class_list":["post-16966","private_project","type-private_project","status-publish","hentry","project_status-completed"],"acf":{"project_id":"P2023-176 \/ 2024 0970 350 000","project_id_year":2023,"ices_scientist":"","principal_investigators":null,"knowledge_user":"","client":"","objectives":"","results":"","availability_of_results":"","pia_approved":null,"infographic":"","sitecore_item_id":"","sitecore_item_name":"","sitecore_field_values":""},"yoast_head":"\nBurden of illness of sickle cell disease with recurrent vaso-occlusive crises (VOCs) in Ontario | ICES<\/title>\n<meta name=\"description\" content=\"Client: IQVIA Solutions Canada Inc. Project ID: P2023-176 \/ 2024 0970 350 000 Research Question\/Objectives: The prevalence of complications and healthcare\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-of-sickle-cell-disease-with-recurrent-vocs-in-ontario\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Burden of illness of sickle cell disease with recurrent vaso-occlusive crises (VOCs) in Ontario | ICES\" \/>\n<meta property=\"og:description\" content=\"Client: IQVIA Solutions Canada Inc. Project ID: P2023-176 \/ 2024 0970 350 000 Research Question\/Objectives: The prevalence of complications and healthcare\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-of-sickle-cell-disease-with-recurrent-vocs-in-ontario\/\" \/>\n<meta property=\"og:site_name\" content=\"ICES\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ICESOntario\/\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-28T16:09:53+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/burden-of-illness-of-sickle-cell-disease-with-recurrent-vocs-in-ontario\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/burden-of-illness-of-sickle-cell-disease-with-recurrent-vocs-in-ontario\\\/\",\"name\":\"Burden of illness of sickle cell disease with recurrent vaso-occlusive crises (VOCs) in Ontario | ICES\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\"},\"datePublished\":\"2023-11-09T18:25:35+00:00\",\"dateModified\":\"2025-02-28T16:09:53+00:00\",\"description\":\"Client: IQVIA Solutions Canada Inc. Project ID: P2023-176 \\\/ 2024 0970 350 000 Research Question\\\/Objectives: The prevalence of complications and healthcare\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/burden-of-illness-of-sickle-cell-disease-with-recurrent-vocs-in-ontario\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/burden-of-illness-of-sickle-cell-disease-with-recurrent-vocs-in-ontario\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/burden-of-illness-of-sickle-cell-disease-with-recurrent-vocs-in-ontario\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Private Sector Projects\",\"item\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/services-for-researchers\\\/all-projects\\\/private-sector-projects\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Burden of illness of sickle cell disease with recurrent vaso-occlusive crises (VOCs) in Ontario\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"name\":\"ICES\",\"description\":\"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\"},\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#organization\",\"name\":\"ICES\",\"alternateName\":\"Institute for Clinical Evaluative Sciences\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.ices.on.ca\\\/wp-content\\\/uploads\\\/2023\\\/04\\\/ices-logo.png\",\"width\":\"676\",\"height\":\"618\",\"caption\":\"ICES\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ices.on.ca\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ICESOntario\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ices-research-institute\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Burden of illness of sickle cell disease with recurrent vaso-occlusive crises (VOCs) in Ontario | ICES","description":"Client: IQVIA Solutions Canada Inc. Project ID: P2023-176 \/ 2024 0970 350 000 Research Question\/Objectives: The prevalence of complications and healthcare","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-of-sickle-cell-disease-with-recurrent-vocs-in-ontario\/","og_locale":"fr_FR","og_type":"article","og_title":"Burden of illness of sickle cell disease with recurrent vaso-occlusive crises (VOCs) in Ontario | ICES","og_description":"Client: IQVIA Solutions Canada Inc. Project ID: P2023-176 \/ 2024 0970 350 000 Research Question\/Objectives: The prevalence of complications and healthcare","og_url":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-of-sickle-cell-disease-with-recurrent-vocs-in-ontario\/","og_site_name":"ICES","article_publisher":"https:\/\/www.facebook.com\/ICESOntario\/","article_modified_time":"2025-02-28T16:09:53+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2024\/11\/ic-es-data-discovery-better-health-logo.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-of-sickle-cell-disease-with-recurrent-vocs-in-ontario\/","url":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-of-sickle-cell-disease-with-recurrent-vocs-in-ontario\/","name":"Burden of illness of sickle cell disease with recurrent vaso-occlusive crises (VOCs) in Ontario | ICES","isPartOf":{"@id":"https:\/\/www.ices.on.ca\/fr\/#website"},"datePublished":"2023-11-09T18:25:35+00:00","dateModified":"2025-02-28T16:09:53+00:00","description":"Client: IQVIA Solutions Canada Inc. Project ID: P2023-176 \/ 2024 0970 350 000 Research Question\/Objectives: The prevalence of complications and healthcare","breadcrumb":{"@id":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-of-sickle-cell-disease-with-recurrent-vocs-in-ontario\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-of-sickle-cell-disease-with-recurrent-vocs-in-ontario\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/burden-of-illness-of-sickle-cell-disease-with-recurrent-vocs-in-ontario\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ices.on.ca\/fr\/"},{"@type":"ListItem","position":2,"name":"Private Sector Projects","item":"https:\/\/www.ices.on.ca\/fr\/services-for-researchers\/all-projects\/private-sector-projects\/"},{"@type":"ListItem","position":3,"name":"Burden of illness of sickle cell disease with recurrent vaso-occlusive crises (VOCs) in Ontario"}]},{"@type":"WebSite","@id":"https:\/\/www.ices.on.ca\/fr\/#website","url":"https:\/\/www.ices.on.ca\/fr\/","name":"ICES","description":"POPULATION-BASED HEALTH RESEARCH THAT MAKES A DIFFERENCE","publisher":{"@id":"https:\/\/www.ices.on.ca\/fr\/#organization"},"alternateName":"Institute for Clinical Evaluative Sciences","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ices.on.ca\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ices.on.ca\/fr\/#organization","name":"ICES","alternateName":"Institute for Clinical Evaluative Sciences","url":"https:\/\/www.ices.on.ca\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","contentUrl":"https:\/\/www.ices.on.ca\/wp-content\/uploads\/2023\/04\/ices-logo.png","width":"676","height":"618","caption":"ICES"},"image":{"@id":"https:\/\/www.ices.on.ca\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ICESOntario\/","https:\/\/www.linkedin.com\/company\/ices-research-institute\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/private_project\/16966","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/private_project"}],"about":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/types\/private_project"}],"wp:attachment":[{"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/media?parent=16966"}],"wp:term":[{"taxonomy":"organization_type","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/organization_type?post=16966"},{"taxonomy":"project_status","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/project_status?post=16966"},{"taxonomy":"response_type","embeddable":true,"href":"https:\/\/www.ices.on.ca\/fr\/wp-json\/wp\/v2\/response_type?post=16966"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}